CIK 0001159036 · Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880488686
- Phone
- (858) 794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,884,955
- in 5 filings, $19.9M under 10b5-1 plans
Net −$19,884,955. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-20 | Torley Helen PRESIDENT AND CEO | Shares withheld for taxes | −9,040 | $70.98 | $642K | 757,448 |
| 2026-02-20 | Torley Helen PRESIDENT AND CEO | Option exercise · Restricted Stock Units | −16,757 | 50,270 | ||
| 2026-02-16 | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | Option exercise | +4,796 | 38,977 | ||
| 2026-02-16 | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | Shares withheld for taxes | −2,587 | $79.44 | $206K | 36,390 |
| 2026-02-16 | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | Option exercise | +12,016 | 48,406 | ||
| 2026-02-16 | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | Shares withheld for taxes | −6,481 | $79.44 | $515K | 41,925 |
| 2026-02-16 | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | Option exercise · Restricted Stock Units | −4,796 | 4,796 | ||
| 2026-02-16 | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | Option exercise · Performance Stock Units | −12,016 | 0 | ||
| 2026-02-16 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Option exercise | +5,093 | 27,172 | ||
| 2026-02-16 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −2,747 | $79.44 | $218K | 24,425 |
| 2026-02-16 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Option exercise | +5,329 | 29,754 | ||
| 2026-02-16 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −2,874 | $79.44 | $228K | 26,880 |
| 2026-02-16 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Option exercise | +13,351 | 40,231 | ||
| 2026-02-16 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −7,273 | $79.44 | $578K | 32,958 |
| 2026-02-16 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Units | −5,093 | 0 | ||
| 2026-02-16 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Units | −5,329 | 5,329 | ||
| 2026-02-16 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Option exercise · Performance Stock Units | −13,351 | 0 | ||
| 2026-02-16 | Torley Helen PRESIDENT AND CEO | Option exercise | +21,009 | 729,728 | ||
| 2026-02-16 | Torley Helen PRESIDENT AND CEO | Shares withheld for taxes | −11,334 | $79.44 | $900K | 718,394 |
| 2026-02-16 | Torley Helen PRESIDENT AND CEO | Option exercise | +16,875 | 735,269 |
Page 10 of 26 · 513 trades